BORCS5

Across TCGA pan-cancer cohorts, BORCS5 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of BORCS5’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where BORCS5 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types BORCS5 is over-expressed in tumor, although a few such as LSCC and HNSC show the opposite, repressed pattern.

LSCC, HNSC, and LUAD are the cancer types where BORCS5 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BORCS5 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	II,III,IV	−0.320	<.001	9	view →
HNSC	Male	II,III,IV	−0.323	<.001	8	view →
LUAD	Male	III,IV	−0.323	<.001	8	view →
CCRCC	Male	All	+0.085	.002	4	view →
COAD	All	III,IV	+0.249	.026	2	view →
PDAC	All	IV	−0.517	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

BORCS5–LSCC

Open the LSCC breakdown →